IFNG and B-cell chronic lymphocytic leukemia: We treated cells derived from six patients with CLL with 0.1% DMSO (vehicle control), 50 μM BIRB796, 100 ng/mL IFNγ, 1 nM venetoclax, and the indicated combinations for 24 h (Fig. 5b).